BAT Sells 3.5% Stake in ITC for $2.1 Billion

BAT by 2FIRSTS.ai
Mar.14.2024
BAT Sells 3.5% Stake in ITC for $2.1 Billion
British American Tobacco (BAT) sells 3.5% stake in India's ITC Ltd for $2.1 billion, retaining 25.5% ownership.

According to a report from the Indian media outlet Theweek, British American Tobacco (BAT) sold a 3.5% stake in Indian Tobacco Company (ITC Ltd) through a public market transaction on March 13, with the total transaction amount reaching 174.85 billion rupees ($2.1 billion USD).

 

Despite completing this major transaction, BAT remains an important shareholder of ITC, holding a 25.5% stake in the company. Other shareholders of ITC include the Singapore government, Singapore Monetary Authority, Lockheed Martin Corporation, Goldman Sachs (Singapore), Copthall Mauritius Investments, BofA Securities Europe SA, Societe Generale, Morgan Stanley Asia Singapore Limited, and Ghisallo Master Fund LP.

 

BAT has sold over 436.8 million equity shares through its subsidiary India Tobacco Manufacturers (India) Ltd, in 48 transactions, equivalent to a 3.5% stake in ITC. The average selling price for these shares was 400.25 Indian rupees per share, with a total transaction value of 174.85 billion Indian rupees.

 

Over 30 institutions purchased shares in this sale, including ICICI Prudential Mutual Fund, Motilal Oswal MF, Nippon India MF, SBI MF, Max Life Insurance Company, IMF, Capital Group, Kuwait Investment Authority, The People's Bank of China, and International Bank for Reconstruction and Development.

 

It is reported that BAT plans to use the net proceeds from this bulk transaction to buy back its own shares by December 2025, starting as early as 2024, with a total amount of up to 700 million pounds. In addition, BAT will continue to use operating cash flow to fund its transformation and further reduce debt.

 

The initial investment by BAT in ITC can be traced back to the early 20th century, with both companies maintaining a mutually beneficial relationship for an extended period of time.

 

Notice

1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.

2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.

3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.

Copyright

This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.

This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.

Health Canada Issues Recall for "Crystal" E-cigarette Liquid Products
Health Canada Issues Recall for "Crystal" E-cigarette Liquid Products
Health Canada has issued a recall for 250ml bottles of "Crystal" e-cigarette liquid due to safety concerns, citing the potential health risks.
Apr.25 by 2FIRSTS.ai
2Firsts Exclusive PMTA Product: PMTA SUPER MODULE PLAN
2Firsts Exclusive PMTA Product: PMTA SUPER MODULE PLAN
2Firsts launches an exclusive PMTA Super Service Plan featuring the Acceptance Pro Solution and SciAsset Filing Plans.
May.22
MGH Study: Varenicline Boosts Young Adults’ E-Cigarette Quit Rates by 50%
MGH Study: Varenicline Boosts Young Adults’ E-Cigarette Quit Rates by 50%
A study by Massachusetts General Hospital found that the oral smoking cessation drug varenicline significantly improves e-cigarette quit rates among young people aged 16 to 25. In a 12-week trial, 50% of participants in the varenicline group successfully quit vaping, compared to just 14% in the placebo group. After six months, 28% of those in the treatment group remained vape-free.
Apr.24 by 2FIRSTS.ai
Philippines Seizes 81,000 “TEAM PAPA” Vape Pods Worth Over $9.7 Million
Philippines Seizes 81,000 “TEAM PAPA” Vape Pods Worth Over $9.7 Million
On May 8, Philippine authorities raided a home in Marilao, Bulacan, and seized 81,200 illegal “TEAM PAPA” vape pods. The bust, led by the Bureau of Internal Revenue and National Bureau of Investigation, involves an estimated $9.7 million in taxes and penalties.
May.16 by 2FIRSTS.ai
Dutch Medical Institutions Urge Snapchat to Crack Down on E-cigarette Sales Content
Dutch Medical Institutions Urge Snapchat to Crack Down on E-cigarette Sales Content
Several Dutch medical and public health organizations have jointly sent a letter to Snapchat, urging the platform to strengthen its efforts in curbing e-cigarette promotion to protect youth from nicotine addiction. If no improvement is seen within 14 days, a formal complaint will be filed.
Jun.12 by 2FIRSTS.ai
With Illegal E-Cigs Dominating 90% Market, Can American Democrats and Republicans Jointly 'End' the Gray Zone?
With Illegal E-Cigs Dominating 90% Market, Can American Democrats and Republicans Jointly 'End' the Gray Zone?
US House Oversight Committee Holds Hearing on Restoring Trust in FDA, Addressing Illicit Products; Controversy Surrounds Approval Process.
Apr.22 by 2FIRSTS.ai